Basel, Monday, 3 February 2025.Roche leverages digital health innovations to offer precise, personalized care, improving patient outcomes globally through new medicines, diagnostics, and applications utilizing cutting-edge technology.
Strategic Leadership Transformation
Roche is strengthening its digital health capabilities with the appointment of Wafaa Mamilli as Chief Digital Technology Officer, effective February 10, 2025 [1][2]. Reporting directly to CEO Thomas Schinecker, Mamilli brings extensive experience from her previous role as Chief Digital & Technology Officer at Zoetis and her two-decade tenure at Eli Lilly [3]. This strategic appointment comes as Roche intensifies its focus on enterprise-wide AI deployment and digital transformation [2].
AI-Driven Healthcare Innovation
The company has made significant strides in AI implementation, particularly in cancer research and diagnosis. In 2024, Roche expanded its Digital Pathology Open Environment, integrating more than 20 AI algorithms from eight new collaborating partners [2]. The company’s commitment to leveraging digital technology is further evidenced by CEO Thomas Schinecker’s push for increased AI utilization throughout the drug development process [2][4].
Advanced Diagnostic Solutions
Roche’s digital health initiatives are yielding tangible results in diagnostic capabilities. The company has achieved FDA approval for the Roche Blood Safety Solution for blood donor screening in the US market, the largest donor screening market globally [5]. Additionally, both the cobas® pro serology solution and the DP600 scanner have received 510(k) clearance for primary diagnosis in the US [5], demonstrating Roche’s commitment to advancing diagnostic technology.
Future Growth and Sustainability
Looking ahead, Roche has set ambitious targets for its digital health initiatives. The company aims to achieve CHF 1 billion in revenue from its cobas® Mass Spectrometry solution by the end of the decade [5]. Under Mamilli’s leadership, Roche is positioned to further advance its digital capabilities, with a particular focus on AI-driven healthcare solutions [3]. ‘Technology—and particularly AI—has never been more promising in shaping the future of healthcare,’ states Mamilli [4].
